I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 25% ± 7% | |
| glutamatergic neuron | 3 studies | 35% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 25% ± 7% | |
| glutamatergic neuron | 3 studies | 35% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 26% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 739.92 | 2639 / 2642 | 99% | 12.02 | 700 / 705 |
| thymus | 100% | 318.46 | 650 / 653 | 92% | 7.18 | 558 / 605 |
| breast | 100% | 332.72 | 459 / 459 | 88% | 5.50 | 981 / 1118 |
| skin | 95% | 241.87 | 1712 / 1809 | 88% | 5.16 | 417 / 472 |
| intestine | 96% | 282.60 | 930 / 966 | 80% | 3.86 | 419 / 527 |
| ovary | 100% | 472.89 | 180 / 180 | 75% | 3.87 | 324 / 430 |
| uterus | 100% | 597.94 | 170 / 170 | 72% | 4.66 | 330 / 459 |
| lung | 97% | 267.42 | 561 / 578 | 73% | 3.54 | 845 / 1155 |
| prostate | 100% | 350.99 | 244 / 245 | 66% | 2.39 | 331 / 502 |
| adrenal gland | 96% | 207.22 | 248 / 258 | 68% | 3.26 | 157 / 230 |
| bladder | 95% | 311.05 | 20 / 21 | 61% | 3.31 | 306 / 504 |
| esophagus | 89% | 272.90 | 1287 / 1445 | 66% | 3.12 | 121 / 183 |
| stomach | 66% | 150.99 | 237 / 359 | 74% | 3.41 | 213 / 286 |
| kidney | 92% | 158.15 | 82 / 89 | 40% | 1.43 | 359 / 901 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.74 | 1 / 1 |
| blood vessel | 100% | 409.36 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 315.85 | 1200 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 98% | 216.17 | 236 / 241 | 0% | 0 | 0 / 0 |
| pancreas | 23% | 30.66 | 77 / 328 | 72% | 2.79 | 129 / 178 |
| eye | 0% | 0 | 0 / 0 | 90% | 5.40 | 72 / 80 |
| heart | 71% | 115.13 | 615 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 69% | 3.23 | 20 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 64% | 3.52 | 29 / 45 |
| peripheral blood | 19% | 80.95 | 175 / 929 | 0% | 0 | 0 / 0 |
| liver | 3% | 3.90 | 7 / 226 | 13% | 0.73 | 53 / 406 |
| muscle | 12% | 13.68 | 93 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0120009 | Biological process | intermembrane lipid transfer |
| GO_0015914 | Biological process | phospholipid transport |
| GO_0005758 | Cellular component | mitochondrial intermembrane space |
| GO_1990050 | Molecular function | phosphatidic acid transfer activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PRELID3A |
| Protein name | PRELI domain containing protein 3A (Protein slowmo homolog 1) PRELI domain containing 3A |
| Synonyms | C18orf43 SLMO1 |
| Description | FUNCTION: In vitro, the TRIAP1:PRELID3A complex mediates the transfer of phosphatidic acid (PA) between liposomes and probably functions as a PA transporter across the mitochondrion intermembrane space. Phosphatidic acid import is required for cardiolipin (CL) synthesis in the mitochondrial inner membrane. . |
| Accessions | ENST00000336990.8 [Q96N28-1] ENST00000587862.5 K7EPM9 Q96N28 ENST00000587735.1 K7EQM5 K7ELB4 ENST00000588729.5 ENST00000590956.5 ENST00000592149.5 [Q96N28-2] K7EP78 ENST00000440960.6 [Q96N28-1] K7ENN4 ENST00000589952.5 ENST00000589565.1 |
